Pillsbury Winthrop Shaw Pittman LLP advised Netskope on the deal while Sidley represented Goldman Sachs Asset Management. Latham & Watkins LLP represented Morgan Stanley Tactical Value....
Netskope’s $401 Million Investment Round
Lyft’s $420 Million Debt Financing
Latham & Watkins LLP represented Lyft in the transaction. Lyft, Inc. (Nasdaq: LYFT) has announced that it entered into a Revolving Credit Agreement which provides the...
Kura Oncology’s $125 Million Financing Agreement
Latham & Watkins LLP represented Hercules Capital, Inc. in the transaction. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
Outset Medical’s $300 Million Debt Facilities
Cooley LLP advised Outset, while Latham & Watkins LLP represented SLR Capital Partners in the transaction. Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering...
Tricida’s $125 Million Debt Facility
Latham & Watkins LLP represented Hercules in the transaction. Tricida, Inc. (Nasdaq: TCDA) has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a...
Alphatec Spine’s $50 Million Revolving Credit Facility
Latham & Watkins represented Alphatec in the transaction. Alphatec Holdings, Inc. (Alphatec) announced the close of an asset-based revolving credit facility in the maximum aggregate amount...
Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners
Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...
Alignment Healthcare’ $250 Million Debt Financing
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
Marti’s Merger with Galata Acquisition Corp.
Latham & Watkins and Conyers represented Marti Technologies Inc. in the transaction. Willkie Farr & Gallagher represented Galata. White & Case represented B. Riley Securities. Galata Acquisition...
Rhythm Pharmaceuticals’ $100 Million Revenue Interest Financing Agreement With HealthCare Royalty Partners
Latham & Watkins represented Rhythm Pharmaceuticals, Inc. in the transaction, while Morgan, Lewis & Bockius acted as legal advisor to HealthCare Royalty. Rhythm Pharmaceuticals, Inc. (Nasdaq:...
SatixFy’s $813 Million Combination With Endurance Acquisition
Davis Polk and Gross & Co. advised SatixFy Communications Ltd. on the deal. Appleby and Morrison & Foerster acted for Endurance Acquisition Corp. Latham & Watkins...
Arcutis Biotherapeutics’ $225 Million Non-Dilutive Debt Financing
Latham & Watkins represented Arcutis in the transaction. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing novel innovations in immuno-dermatology, has announced that...